Assessing the transition from intravenous to subcutaneous delivery of rituximab: Benefits for payers, health care professionals, and patients with lymphoma
Article in PLOS ONE (January 2022)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in PLOS ONE (January 2022)
Article in Cancer Medicine (May 2018)
Article in Medicine (November 2016)